Deutsche Bank’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History
Bought
Maintained
Sold
Other funds holding ASLN
SCM
PIM
DCM
Deutsche Bank's ASLN Position: Q2 2020 in Review
Deutsche Bank sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q2 2020, closing a stake of 30 shares — an estimated $1K sold.
Deutsche Bank first reported a position in ASLN in Q3 2019 and held it in 3 quarters. The position peaked at $4K in Q4 2019. 9 funds tracked by Wall St. Rank hold ASLN as of Q2 2020.
- Deutsche Bank reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q2 2020 after selling out during the quarter.
- Deutsche Bank sold 30 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q2 2020, an estimated $1K.
- Deutsche Bank first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2019 and held it in 3 quarters.
- Deutsche Bank's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $4K in Q4 2019.
- 9 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q2 2020.
Based on Deutsche Bank's 13F filing for Q2 2020, filed 13 Aug 2020.